Basic Information
Basic information for LINC00221-202-85aa
Peptide Name LINC00221-202-85aa
Genome Position chr14:106504856-106505072,106506357-106506394[+]
Species Human
Peptide Sequence MLDASCPRTSDSKFFSFFTLGLKPVVCQGLSGLWRQTEGCTVVFLTFEVLGLGLASLLLSLQTAYHETSSCDRTHSKNLLCFKIV
Peptide Length 85
Unique Yes
Grand Average of Hydropathicity 0.4024
Relative Molecular Mass 10879.44
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000270816;LINC00221
Transcript ID/Name ENST00000619530;LINC00221-202
Transcript Length 1499
Coding Ability 0.3476
DNA Sequence Corresponding to Peptide ATGCTGGATGCTTCCTGCCCTCGAACATCAGACTCCAAGTTCTTCAGCTTTTTCACTCTTGGACTTAAGCCAGTGGTTTGCCAGGGGCTCTCTGGCCTTTGGCGACAGACCGAAGGCTGCACCGTCGTCTTCCTGACTTTCGAGGTTTTGGGACTTGGACTGGCTTCCTTGCTCCTCAGCTTGCAGACGGCCTATCACGAGACTTCATCTTGTGATCGAACCCACTCGAAGAACCTGTTGTGCTTCAAGATAGTT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :